Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation

被引:0
|
作者
Mattsson, J. [1 ]
Svenberg, P. [1 ]
Gustafsson, B.
Remberger, M.
Ringden, O. [1 ]
机构
[1] Ctr Allogen Stem Cell Transpl, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S234 / S234
页数:1
相关论文
共 50 条
  • [1] Sirolimus and tacrolimus as graft-versus-host disease prophylaxis in allogeneic stem cell transplantation: The Dana Farber Cancer Institute experience
    Cutler, C
    Li, S
    Kim, HT
    Alyea, E
    Ho, V
    Lee, SJ
    Soiffer, R
    Antin, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 3 - 4
  • [2] Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
    Mirza, Abu-Sayeef
    Tandon, Ankita
    Jenneman, Dakota
    Cao, Shu
    Brimer, Thomas
    Kumar, Ambuj
    Kidd, Michelle
    Khimani, Farhad
    Faramand, Rawan
    Mishra, Asmita
    Liu, Hien
    Nishihori, Taiga
    Perez, Lia
    Lazaryan, Aleksandr
    Bejanyan, Nelli
    Nieder, Michael
    Anasetti, Claudio
    Pidala, Joseph
    Elmariah, Hany
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 185.e1 - 185.e7
  • [3] A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
    Torlen, Johan
    Ringden, Olle
    Garming-Legert, Karin
    Ljungman, Per
    Winiarski, Jacek
    Remes, Kari
    Itala-Remes, Maija
    Remberger, Mats
    Mattsson, Jonas
    HAEMATOLOGICA, 2016, 101 (11) : 1417 - 1425
  • [4] Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant
    Mirza, Sayeef
    Tandon, Ankita
    Jenneman, Dakota
    Cao, Shu
    Kumar, Ambuj
    Kidd, Michelle R.
    Khimani, Farhad
    Mishra, Asmita
    Liu, Hien D.
    Nishihori, Taiga
    Perez, Lia
    Bejanyan, Nelli
    Pidala, Joseph
    Nieder, Michael
    Elmariah, Hany
    BLOOD, 2019, 134
  • [5] Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
    Shayani, Sepideh
    Palmer, Joycelynne
    Stiller, Tracey
    Liu, Xueli
    Thomas, Sandra H.
    Khuu, Tam
    Parker, Pablo M.
    Khaled, Samer K.
    Forman, Stephen J.
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 298 - 304
  • [6] Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease
    Greco, Raffaella
    Barbanti, Maria Chiara
    Forcina, Alessandra
    Stanghellini, Maria Teresa Lupo
    Giglio, Fabio
    Morelli, Mara
    Vago, Luca
    Piemontese, Simona
    Messina, Carlo
    Sala, Elisa
    Pavesi, Francesca
    Marktel, Sarah
    Carrabba, Matteo G.
    Assanelli, Andrea
    Bernardi, Massimo
    Peccatori, Jacopo
    Corti, Consuelo
    Ciceri, Fabio
    BLOOD, 2015, 126 (23)
  • [7] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Stankevich, Y.
    Zubarovskaya, L.
    Vavilov, V.
    Bondarenko, S.
    Darskaya, E.
    Kulagin, A.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S153 - S154
  • [8] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763
  • [9] Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
    Cutler, C
    Kim, HT
    Hochberg, E
    Ho, V
    Alyea, E
    Lee, SJ
    Fisher, DC
    Miklos, D
    Levin, J
    Sonis, S
    Soiffer, RJ
    Antin, JH
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (05) : 328 - 336
  • [10] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    TRANSPLANTATION, 1999, 67 (04) : 499 - 504